V. Balzani, J. F. Stoddart, D. J. Williams et al.
FULL PAPER
1
and dried in vacuo (708C/0.1 Torr). Yield 0.31 g (25%), m.p. > 3008C; H
NMR (300 MHz, CD3SOCD3, 258C): d 5.97 (s, 8H; NCH2), 7.93 (d, J
5 Hz, 4H; PyH-5), 8.39 (s, 4H; PyH-3), 8.58 (d, J 7 Hz, 8H; b-CH), 8.81
(d, J 5 Hz, 4H; PyH-6), 9.55 (d, J 7 Hz, 8H; a-CH); 13C NMR
(75.5 MHz, CD3SOCD3, 258C): d 62.3 (CH2), 121.6, 125.0, 127.3, 145.4,
4H; a-CH), 8.88 (d, J 7 Hz, 4H; a'-CH); 13C NMR (75.5 MHz, CD3CN,
258C): d 63.2, 65.7 (CH2), 125.1, 126.1, 128.4, 128.6, 130.0, 131.4, 18.9,
145.9, 146.4, 152.4, 152.8, 153.7 (CH), 136.8, 141.9, 151.0, 151.3, 157.6, 158.5
(Cq); MS (LSIMS): m/z 1737 [M PF6] , 1592 [M 2PF6] , 1447 [M
3PF6] ; C60H50F36N10P6Ru (1882.0): calcd C 38.29, H 2.68, N 7.44; found C
150.8 (CH), 144.3, 149.0, 156.2 (Cq); MS (LSIMS): m/z 1111 [M PF6] ,
38.27, H 2.84, N 7.42.
966 [M 2PF6] , 821 [M 3PF6] ; C44H34F24N8P4 (1256.7): calcd C 42.05,
[{Ru(bpy)2}2L2](PF6)8: From [Ru(bpy)2Cl2] (53.2 mg, 0.11 mmol) and L2 ´
4PF6 (62.8 mg, 0.05 mmol) in EtOH/H2O (20 mL); yield 127 mg (97%),
m.p. 2408C (decomp.); 1H NMR (400 MHz, CD3CN, 258C, 2D COSY 45):
d 5.89 (s, 8H; NCH2), 7.39 (m, 8H; bpyH-4), 7.64 (dd, J 6.0, 2.0 Hz; 4H;
PyH-5), 7.69 (m, 8H; bpyH-3), 7.89 (d, J 6 Hz, 4H; PyH-6), 8.07 (m, 8H;
bpyH-5), 8.28 (d, J 7 Hz, 8H; b-CH), 8.30 (brs, 4H; PyH-3), 8.50 (d, J
8 Hz, 8H; bpyH-6), 8.96 (d, J 7 Hz, 8H; a-CH); 13C NMR (75.5 MHz,
CD3CN, 258C): d 63.2 (CH2), 125.2, 125.6, 128.7, 129.5, 139.0, 146.7, 152.3,
152.7, 153.6 (CH), 142.5, 157.6, 158.4 (Cq); MS (LSIMS): m/z 2519 [M
H 2.89, N 8.92; found C 42.03, H 2.81, N 8.76.
[2]Catenane L3 ´ 4PF6: The dibromide 5e (40 mg, 0.12 mmol), 6 ´ 2PF6
(75 mg, 0.11 mmol), and the macrocyclic polyether BPP34C10 (142 mg,
0.27 mmol) were dissolved in dry MeCN (30 mL). The solution was stirred
at room temperature for 14 d. The deep red solution was concentrated in
vacuo and the residue was purified by flash column chromatography (SiO2,
eluent MeOH/2m NH4Cl/MeNO2, 7:2:1) affording, after counterion
exchange, L3 ´ 4PF6 as a red solid (55 mg, 30%). M.p. > 2508C; 1H NMR
(300 MHz, CD3COCD3, 258C, TMS): d 3.51 ± 4.12 (m, 32H; OCH2), 5.23
(brs, 8H; OC6H4), 6.12 (s, 4H; NCH2), 6.18 (s, 4H; NCH2), 7.93 (d, 2H;
PyH-5), 8.04 (s, 4H; C6H4), 8.12 (m, 8H; b-CH), 8.18 (s, 2H; PyH-3), 8.92
(d, 2H; PyH-6), 9.38 and 9.43 (2 Â d, 2 Â 4H; a-CH); 13C NMR (75.5 MHz,
CD3COCD3, 258C): d 64.2, 65.5, 68.0, 68.7, 70.6, 70.8, 71.3 (CH2), 123.5,
125.0, 126.7, 126.9, 131.6, 146.0, 146.3, 151.8 (CH), 137.2, 144.2, 148.0, 159.4
PF6] , 2375 [M 2PF6] , 2229 [M 3PF6] ; C84H68F48N16P8Ru2 (2663.4):
calcd C 37.88, H 2.57, N 8.41; found C 37.66, H 2.62, N 8.42. Single crystals
suitable for X-ray crystallography were obtained by slow evaporation of
Me2CO from a mixture Me2CO/C6H6 solution of the complex.
[Ru(bpy)2L3](PF6)6: From [Ru(bpy)2Cl2] (48 mg, 0.03 mmol) and L3 ´ 4PF6
1
(13 mg, 0.03 mmol) in EtOH/H2O (20 mL); yield 60 mg (82%). H NMR
(Cq); MS (LSIMS): m/z 1570 [M PF6] , 1424 [M 2PF6] .
C68H74F24N6O10P4 (1712.4): calcd C 47.61, H 4.4.32, N 4.90; found C 47.54,
H 4.39, N 4.93.
(300 MHz, CD3COCD3, 258C): d 3.3 ± 4.0 (m, 36H; OCH2 alongside
OC6H4), 6.12 (s, 4H; NCH2), 6.24 (brs, 4H; inside OC6H4), 6.24 (s, 4H;
NCH2), 7.9 ± 8.3 (m, 26H; b-CH and C6H4 and PyH), 7.5 ± 7.7 (m, 4H; PyH),
8.75 ± 8.84 (m, 6H; PyH-6), 8.96 and 9.24 (2 Â d, 2 Â 4H; a-CH); 13C NMR
(75.5 MHz, CD3COCD3, 258C): d 63.0, 65.5, 70.6, 70.8, 70.9 (CH2), 125.2,
125.4, 125.5, 125.6, 126.3, 126.9, 128.6, 128.8, 128.9, 129.2, 131.5, 131.9, 157.6,
157.8 (CH), 115.8, 139.2, 139.4, 146.7, 152.5, 152.9, 154.5, 157.9, 158.5 (Cq);
[2]Catenane L4 ´ 4PF6: The dibromide 5e (150 mg, 0.44 mmol), 7 ´ 2PF6
(282 mg, 0.4 mmol),[4] and the macrocyclic polyether 1/5DN38C10 (127 mg,
0.2 mmol) were dissolved in warm, dry DMF (7 mL). The solution was
transferred to an ultrahigh-pressure Teflon reaction vessel, which was then
compressed (12 kbar) at 208C for 3 d. After decompression of the reaction
vessel, the deep red solution was concentrated in vacuo. The residue was
purified by flash column chromatography (SiO2, eluent MeOH/2m NH4Cl/
MeNO2, 7:2:1). The fractions containing the catenane were combined and
concentrated in vacuo. The solid residue was dissolved in H2O and treated
with an excess of 50% NH4PF6 solution. The precipitate was filtered off,
washed with H2O, and dried in vacuo (708C/0.1 Torr) to afford 150 mg
(41%) [2]catenane L4 ´ 4PF6 as a deep pink solid, m.p. 2628C (decomp.). 1H
NMR (400 MHz, CD3COCD3, 243 K, 2D COSY 45): d 3.29 (d, 1H;
NpH), 3.53 ± 4.33 (m, 32H; OCH2), 4.65 (d, 1H; NpH), 5.38 (t, 1H; NpH),
5.62 (t, 1H; NpH), 5.92 ± 6.30 (m, 8H; NCH2), 6.07 (d, 1H; NpH), 6.18 (d,
1H; NpH), 6.36 (d, 1H; NpH), 6.46 (d, 1H; NpH), 7.00 (m, 3H; NpH and
PyH-5), 7.14 (d, 3H; NpH and PyH-5'), 7.33 (brs, 2H; b-CH), 7.69 (brs, 2H;
b'-CH), 7.84 (brs, 2H; b-CH), 7.98 (brs, 2H; b-CH), 8.00 (brs, 2H; C6H4),
8.15 (brs, 1H; PyH-3), 8.31 (brs, 2H; C6H4), 8.38 (brs, 1H; PyH-3'), 8.73
(brs, 1H; PyH-6), 8.79 (brs, 1H; PyH-6'), 9.04 (d, 2H; a-CH), 9.11 (brs,
2H; a-CH), 9.20 (brs, 2H; a-CH), 9.38 (brs, 2H; a-CH); 13C NMR
(100 MHz, CD3COCD3, 213 K): d 64.2, 65.6, 68.1, 68.5, 70.4, 70.6, 71.2,
72.1 (CH2), 104.6, 105.5, 106.5, 110.2, 111.1, 114.5, 125.3, 125.6, 126.3, 126.9,
131.6, 145.2, 145.5 (CH), 124.6, 124.9, 137.5, 144.0, 152.5, 154.1 (Cq); MS
MS (LSIMS): m/z 2273 [M PF6] , 2128 [M 2PF6] .
[Ru(bpy)2L4](PF6)6: From [Ru(bpy)2Cl2] (24.2 mg, 0.05 mmol) and L4 ´
4PF6 (100 mg, 0.054 mmol) in EtOH/H2O (40 mL); yield 118 mg (82%);
m.p. 2018C (decomp.); 13C NMR (100 MHz, CD3CN, 318C): d 62.9, 66.0,
68.9, 69.1, 69.2, 69.4, 70.2, 70.4, 70.7, 71.1, 71.2, 71.5, 72.0, 72.2, 72.6 (CH2),
105.5, 106.5, 106.9, 106.9, 110.4, 111.4, 114.7, 115.0, 124.4, 124.5, 125.5, 125.6,
125.6, 125.7, 126.4, 126.6, 127.0, 127.2, 127.7, 128.9, 129.0, 129.1, 131.7, 131.9,
132.0, 139.5, 139.7, 145.0, 146.2, 152.4, 152.4, 152.6, 152.8, 155.1, 155.2 (CH),
137.8, 137.9, 142.4, 153.3, 154.2, 154.8, 157.7, 157.8, 158.0, 158.0, 158.1 (Cq);
MS (LSIMS): m/z 2373 [M PF6] , 2229 [M 2PF6] , 2084 [M 3PF6] ;
C96H94F36N10O10P6Ru (2518.7): calcd C 45.78, H 3.76, N 5.56; found C 45.87,
H 3.85, N 5.49.
General procedure for synthesis of ReI complexes [Re(CO)3ClL1](PF6)4,
[Re(CO)3Cl]2L2](PF6)4, and [Re(CO)3ClL4](PF6)4: A mixture of [Re-
(CO)5Cl] and the appropriate ligand (L1 ´ 4PF6, L2 ´ 4PF6, or L4 ´ 4PF6) in
anhydrous MeOH was heated under reflux and under an atmosphere of N2
for 24 h. After cooling in a refrigerator, the yellow precipitate was filtered
off, washed with THF and Et2O, and dried in vacuo.
[Re(CO)3ClL1](PF6)4: From [Re(CO)5Cl] (80 mg, 0.22 mmol) and L1 ´ 4PF6
(236 mg, 0.20 mmol) in of MeOH (25 mL); yield 234 mg (79%), m.p. 2688C
(decomp.). 1H NMR (300 MHz, CD3CN, 258C): d 5.79 (s, 4H; xylyl
NCH2), 5.96 (s, 4H; Py NCH2), 7.64 (s, 4H; C6H4), 7.96 (dd, J 6.0, 2.0 Hz;
2H; PyH-5), 8.22 (d, J 7 Hz, 4H; b-CH), 8.25 (d, J 7 Hz, 4H; b'-CH),
8.94 (d, J 7 Hz, 4H; a-CH), 9.02 (brs, 2H; PyH-3), 9.15 (d, J 6 Hz, 2H;
PyH-6), 9.34 (d, J 7 Hz, 4H; a'-CH); 13C NMR (75.5 MHz, CD3CN,
258C): d 63.4, 65.7 (CH2), 126.5, 128.4, 128.6, 130.2, 131.5, 146.0, 147.2,
(LSIMS): m/z 1814 [M] , 1669 [M PF6] , 1524 [M 2PF6] , 1379 [M
3PF6] ; C76H78F24N6O10P4 (1815.4): calcd C 50.28, H 4.33, N 4.63; found C
50.39, H 4.19, N 4.82. Single crystals suitable for X-ray crystallography were
grown by vapor diffusion of iPr2O into a 1:1 MeCN/MeNO2 solution of L4 ´
4PF6.
General procedure for synthesis of bis-heteroleptic RuII complexes
[Ru(bpy)2L1](PF6)6, [Ru(bpy)2]2L2](PF6)8, [Ru(bpy)2L3](PF6)6, [Ru-
(bpy)2L4](PF6)6: A mixture of [Ru(bpy)2Cl2] ´ 2H2O and the appropriate
ligand (L1 ´ 4PF6 ± L4 ´ 4PF6) in EtOH/H2O (3:1, v/v) was heated under
reflux under an N2 atmosphere for 48 h. The solvent was removed in vacuo,
and H2O was added to the residue and filtered (to remove an excess of the
ligand). The filtrate was treated with 50% aqueous solution NH4PF6, the
resulting precipitate was filtered off, washed with H2O and Et2O, and dried
in vacuo (608C/0.1 Torr). The compounds were further purified by
precipitation after vapor diffusion of iPr2O into MeCN solutions of the
complexes.
155.1 (CH), 136.9, 145.1, 151.0, 151.4, 157.2 (Cq), 198.3 (C O); MS
(LSIMS): m/z 1339 [M PF6] , 1194 [M 2PF6] , 1049 [M 3PF6] ;
C43H34ClF24O3P4Re (1484.3): calcd C 34.80, H 2.31, N 5.66; found C 34.61, H
2.24, N 5.87. Single crystals suitable for X-ray crystallography were
obtained by vapor diffusion of benzene into
a MeNO2 solution of
[Re(CO)3ClL1](PF6)4.
[Re(CO)3Cl]2L2](PF6)4: From [Re(CO)5Cl] (40.0 mg, 0.11 mmol) and L2 ´
4PF6 (64.0 mg, 0.05 mmol) in MeOH (25 mL); yield 62 mg (66%), m.p. >
3008C (decomp.); 1H NMR (300 MHz, CD3SOCD3, 258C): d 6.12 (s, 8H;
NCH2), 8.15 (d, J 5 Hz, 4H; PyH-5), 8.73 (d, J 5.5 Hz, 8H; b-CH), 8.89
(brs, 4H; PyH-3), 9.20 (d, J 5 Hz, 4H; PyH-6), 9.59 (d, J 6 Hz, 8H; a-
[Ru(bpy)2L1](PF6)6: From [Ru(bpy)2Cl2] (73 mg, 0.15 mmol) and L1 ´ 4PF6
(194 mg, 0.165 mmol) in EtOH/H2O (35 mL); yield 222 mg (94%), m.p.
CH); MS (LSIMS): m/z 1723 [M PF6] , 1578 [M 2PF6] , 1433 [M
1
2388C (decomp.); H NMR (300 MHz, CD3CN, 258C, 2D COSY 45): d
3PF6] ; C50H36Cl2F24O6P4Re2 (1868.1): calcd C 32.15, H 1.94, N 6.00; found
5.79 (s, 4H; xylyl NCH2), 5.81 (s, 4H; PyNCH2), 7.38 (m, 4H; bpyH-4), 7.63
(s, 4H; C6H4), 7.63 ± 7.67 (m, 6H; bpyH-3 and PyH-5), 7.90 (d, J 6 Hz, 2H;
PyH-6), 8.06 (t, J 8 Hz, 4H; bpyH-5), 8.17 (d, J 8 Hz, 8H; b-CH and b'-
CH), 8.33 (s, 2H; PyH-3), 8.50 (d, J 8 Hz, 4H; bpyH-6), 8.84 (d, J 7 Hz,
C 32.06, H 1.92, N 5.93.
[Re(CO)3ClL4](PF6)4: From [Re(CO)5Cl] (12.0 mg, 0.033 mmol) and L4 ´
4PF6 (54.4 mg, 0.030 mg) in MeOH (10 mL). After 24 h under reflux, the
604
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1998
0947-6539/98/0404-0604 $ 17.50+.50/0
Chem. Eur. J. 1998, 4, No. 4